Cargando…

Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan

SIMPLE SUMMARY: A better understanding of the reality for cancer patients during the SARS-CoV-2 (COVID-19) pandemic will help us readapt current prediction models. There is a need to dive into rich data sources from apex cancer centres. The aim of our retrospective study was to report on the outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Monroy-Iglesias, Maria J., Tagliabue, Marta, Dickinson, Harvey, Roberts, Graham, De Berardinis, Rita, Russell, Beth, Moss, Charlotte, Irwin, Sophie, Olsburgh, Jonathon, Cocco, Ivana Maria Francesca, Schizas, Alexis, McCrindle, Sarah, Nath, Rahul, Brunet, Aina, Simo, Ricard, Tornari, Chrysostomos, Srinivasan, Parthi, Prachalias, Andreas, Davies, Andrew, Geh, Jenny, Fraser, Stephanie, Routledge, Tom, Ma, RuJun, Doerge, Ella, Challacombe, Ben, Nair, Raj, Hadjipavlou, Marios, Scarpinata, Rosaria, Sorelli, Paolo, Dolly, Saoirse, Mistretta, Francesco Alessandro, Musi, Gennaro, Casiraghi, Monica, Aloisi, Alessia, Dell’Acqua, Andrea, Scaglione, Donatella, Zanoni, Stefania, Rampazio Da Silva, Daniele, Brambilla, Daniela, Bertolotti, Raffaella, Peruzzotti, Giulia, Maggioni, Angelo, de Cobelli, Ottavio, Spaggiari, Lorenzo, Ansarin, Mohssen, Mastrilli, Fabrizio, Gandini, Sara, Jain, Urvashi, Hamed, Hisham, Haire, Kate, Van Hemelrijck, Mieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036608/
https://www.ncbi.nlm.nih.gov/pubmed/33808375
http://dx.doi.org/10.3390/cancers13071597
_version_ 1783676950130196480
author Monroy-Iglesias, Maria J.
Tagliabue, Marta
Dickinson, Harvey
Roberts, Graham
De Berardinis, Rita
Russell, Beth
Moss, Charlotte
Irwin, Sophie
Olsburgh, Jonathon
Cocco, Ivana Maria Francesca
Schizas, Alexis
McCrindle, Sarah
Nath, Rahul
Brunet, Aina
Simo, Ricard
Tornari, Chrysostomos
Srinivasan, Parthi
Prachalias, Andreas
Davies, Andrew
Geh, Jenny
Fraser, Stephanie
Routledge, Tom
Ma, RuJun
Doerge, Ella
Challacombe, Ben
Nair, Raj
Hadjipavlou, Marios
Scarpinata, Rosaria
Sorelli, Paolo
Dolly, Saoirse
Mistretta, Francesco Alessandro
Musi, Gennaro
Casiraghi, Monica
Aloisi, Alessia
Dell’Acqua, Andrea
Scaglione, Donatella
Zanoni, Stefania
Rampazio Da Silva, Daniele
Brambilla, Daniela
Bertolotti, Raffaella
Peruzzotti, Giulia
Maggioni, Angelo
de Cobelli, Ottavio
Spaggiari, Lorenzo
Ansarin, Mohssen
Mastrilli, Fabrizio
Gandini, Sara
Jain, Urvashi
Hamed, Hisham
Haire, Kate
Van Hemelrijck, Mieke
author_facet Monroy-Iglesias, Maria J.
Tagliabue, Marta
Dickinson, Harvey
Roberts, Graham
De Berardinis, Rita
Russell, Beth
Moss, Charlotte
Irwin, Sophie
Olsburgh, Jonathon
Cocco, Ivana Maria Francesca
Schizas, Alexis
McCrindle, Sarah
Nath, Rahul
Brunet, Aina
Simo, Ricard
Tornari, Chrysostomos
Srinivasan, Parthi
Prachalias, Andreas
Davies, Andrew
Geh, Jenny
Fraser, Stephanie
Routledge, Tom
Ma, RuJun
Doerge, Ella
Challacombe, Ben
Nair, Raj
Hadjipavlou, Marios
Scarpinata, Rosaria
Sorelli, Paolo
Dolly, Saoirse
Mistretta, Francesco Alessandro
Musi, Gennaro
Casiraghi, Monica
Aloisi, Alessia
Dell’Acqua, Andrea
Scaglione, Donatella
Zanoni, Stefania
Rampazio Da Silva, Daniele
Brambilla, Daniela
Bertolotti, Raffaella
Peruzzotti, Giulia
Maggioni, Angelo
de Cobelli, Ottavio
Spaggiari, Lorenzo
Ansarin, Mohssen
Mastrilli, Fabrizio
Gandini, Sara
Jain, Urvashi
Hamed, Hisham
Haire, Kate
Van Hemelrijck, Mieke
author_sort Monroy-Iglesias, Maria J.
collection PubMed
description SIMPLE SUMMARY: A better understanding of the reality for cancer patients during the SARS-CoV-2 (COVID-19) pandemic will help us readapt current prediction models. There is a need to dive into rich data sources from apex cancer centres. The aim of our retrospective study was to report on the outcomes of cancer patients receiving radical surgery with curative intent during the first wave of the COVID-19 pandemic. Data from two cancer centres that were at the epicentre of the outbreak from March to September 2020 (as well as a comparator group in 2019) were utilised for this study. We observed that while there was a decline in number of surgeries performed, the implemented COVID-19 minimal pathways were safe for cancer patients requiring surgical treatment. ABSTRACT: The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections.
format Online
Article
Text
id pubmed-8036608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80366082021-04-12 Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan Monroy-Iglesias, Maria J. Tagliabue, Marta Dickinson, Harvey Roberts, Graham De Berardinis, Rita Russell, Beth Moss, Charlotte Irwin, Sophie Olsburgh, Jonathon Cocco, Ivana Maria Francesca Schizas, Alexis McCrindle, Sarah Nath, Rahul Brunet, Aina Simo, Ricard Tornari, Chrysostomos Srinivasan, Parthi Prachalias, Andreas Davies, Andrew Geh, Jenny Fraser, Stephanie Routledge, Tom Ma, RuJun Doerge, Ella Challacombe, Ben Nair, Raj Hadjipavlou, Marios Scarpinata, Rosaria Sorelli, Paolo Dolly, Saoirse Mistretta, Francesco Alessandro Musi, Gennaro Casiraghi, Monica Aloisi, Alessia Dell’Acqua, Andrea Scaglione, Donatella Zanoni, Stefania Rampazio Da Silva, Daniele Brambilla, Daniela Bertolotti, Raffaella Peruzzotti, Giulia Maggioni, Angelo de Cobelli, Ottavio Spaggiari, Lorenzo Ansarin, Mohssen Mastrilli, Fabrizio Gandini, Sara Jain, Urvashi Hamed, Hisham Haire, Kate Van Hemelrijck, Mieke Cancers (Basel) Article SIMPLE SUMMARY: A better understanding of the reality for cancer patients during the SARS-CoV-2 (COVID-19) pandemic will help us readapt current prediction models. There is a need to dive into rich data sources from apex cancer centres. The aim of our retrospective study was to report on the outcomes of cancer patients receiving radical surgery with curative intent during the first wave of the COVID-19 pandemic. Data from two cancer centres that were at the epicentre of the outbreak from March to September 2020 (as well as a comparator group in 2019) were utilised for this study. We observed that while there was a decline in number of surgeries performed, the implemented COVID-19 minimal pathways were safe for cancer patients requiring surgical treatment. ABSTRACT: The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections. MDPI 2021-03-30 /pmc/articles/PMC8036608/ /pubmed/33808375 http://dx.doi.org/10.3390/cancers13071597 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Monroy-Iglesias, Maria J.
Tagliabue, Marta
Dickinson, Harvey
Roberts, Graham
De Berardinis, Rita
Russell, Beth
Moss, Charlotte
Irwin, Sophie
Olsburgh, Jonathon
Cocco, Ivana Maria Francesca
Schizas, Alexis
McCrindle, Sarah
Nath, Rahul
Brunet, Aina
Simo, Ricard
Tornari, Chrysostomos
Srinivasan, Parthi
Prachalias, Andreas
Davies, Andrew
Geh, Jenny
Fraser, Stephanie
Routledge, Tom
Ma, RuJun
Doerge, Ella
Challacombe, Ben
Nair, Raj
Hadjipavlou, Marios
Scarpinata, Rosaria
Sorelli, Paolo
Dolly, Saoirse
Mistretta, Francesco Alessandro
Musi, Gennaro
Casiraghi, Monica
Aloisi, Alessia
Dell’Acqua, Andrea
Scaglione, Donatella
Zanoni, Stefania
Rampazio Da Silva, Daniele
Brambilla, Daniela
Bertolotti, Raffaella
Peruzzotti, Giulia
Maggioni, Angelo
de Cobelli, Ottavio
Spaggiari, Lorenzo
Ansarin, Mohssen
Mastrilli, Fabrizio
Gandini, Sara
Jain, Urvashi
Hamed, Hisham
Haire, Kate
Van Hemelrijck, Mieke
Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan
title Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan
title_full Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan
title_fullStr Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan
title_full_unstemmed Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan
title_short Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan
title_sort continuity of cancer care: the surgical experience of two large cancer hubs in london and milan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036608/
https://www.ncbi.nlm.nih.gov/pubmed/33808375
http://dx.doi.org/10.3390/cancers13071597
work_keys_str_mv AT monroyiglesiasmariaj continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT tagliabuemarta continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT dickinsonharvey continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT robertsgraham continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT deberardinisrita continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT russellbeth continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT mosscharlotte continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT irwinsophie continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT olsburghjonathon continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT coccoivanamariafrancesca continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT schizasalexis continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT mccrindlesarah continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT nathrahul continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT brunetaina continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT simoricard continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT tornarichrysostomos continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT srinivasanparthi continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT prachaliasandreas continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT daviesandrew continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT gehjenny continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT fraserstephanie continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT routledgetom continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT marujun continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT doergeella continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT challacombeben continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT nairraj continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT hadjipavloumarios continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT scarpinatarosaria continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT sorellipaolo continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT dollysaoirse continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT mistrettafrancescoalessandro continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT musigennaro continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT casiraghimonica continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT aloisialessia continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT dellacquaandrea continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT scaglionedonatella continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT zanonistefania continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT rampaziodasilvadaniele continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT brambilladaniela continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT bertolottiraffaella continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT peruzzottigiulia continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT maggioniangelo continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT decobelliottavio continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT spaggiarilorenzo continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT ansarinmohssen continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT mastrillifabrizio continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT gandinisara continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT jainurvashi continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT hamedhisham continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT hairekate continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan
AT vanhemelrijckmieke continuityofcancercarethesurgicalexperienceoftwolargecancerhubsinlondonandmilan